Anebulo Pharmaceuticals, Inc.
ANEB- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001815974
No open-market purchases or sales by Anebulo Pharmaceuticals, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Anebulo Pharmaceuticals, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 9 | 11 | +2 |
| Shares | 4.68M | 6.84M | +2.17M (+46.3%) |
| Value | $24.3M | $19.2M | −$5.16M (−21.2%) |
New holders (2)
Institutions that held Anebulo Pharmaceuticals, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nantahala Capital Management, LLC | 511,073 | $1.43M | 0.14% |
| Morgan Stanley | 600 | $2.00K | 0.00% |
Sold out (0)
Institutions that held Anebulo Pharmaceuticals, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
None.